Director Lyons Christopher Michael 🟢 acquired 8.3K shares of Sintx Technologies, Inc. (SINT) at $2.96 Transaction Date: Feb 23, 2026 | Filing ID: 009470
(19% Negative) BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) Announces Delay in test Trials for diameter identified by lung cancer screening Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations